SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-005156
Filing Date
2022-02-03
Accepted
2022-02-03 08:31:12
Documents
14
Period of Report
2022-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea154869-8k_bimiint.htm   iXBRL 8-K 28908
2 AMENDMENT NO. 3 TO STOCK PURCHASE AGREEMENT AND SETTLEMENT AGREEMENT DATED FEBRU ea154869ex4-1_bimiint.htm EX-4.1 16026
3 PRESS RELEASE DATED FEBRUARY 2, 2022 ea154869ex99-1_bimiint.htm EX-99.1 9148
  Complete submission text file 0001213900-22-005156.txt   241512

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bimi-20220201.xsd EX-101.SCH 3021
5 XBRL LABEL FILE bimi-20220201_lab.xml EX-101.LAB 35156
6 XBRL PRESENTATION FILE bimi-20220201_pre.xml EX-101.PRE 23021
8 EXTRACTED XBRL INSTANCE DOCUMENT ea154869-8k_bimiint_htm.xml XML 3923
Mailing Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100
Business Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100 (8604) 1182209211
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 22586664
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries